Get the Stockscreener App
2.10
0.48%
0.01
After Hours:
2.07
-0.03
-1.43%
Fractyl Health Inc stock is traded at $2.10, with a volume of 3.93M.
It is up +0.48% in the last 24 hours and down -5.83% over the past month.
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
See More
Previous Close:
$2.09
Open:
$2.09
24h Volume:
3.93M
Relative Volume:
1.34
Market Cap:
$322.08M
Revenue:
-
Net Income/Loss:
$-56.85M
P/E Ratio:
-1.347
EPS:
-1.559
Net Cash Flow:
-
1W Performance:
-4.55%
1M Performance:
-5.83%
6M Performance:
+40.00%
1Y Performance:
+10.53%
1-Day Range:
$2.08
$2.25
1-Week Range:
$1.95
$2.40
52-Week Range:
$0.825
$3.03
Fractyl Health Inc Stock (GUTS) Company Profile
Name
Fractyl Health Inc
Sector
Industry
Phone
781-902-8800
Address
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
2.10 | 320.55M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-25 | Initiated | H.C. Wainwright | Buy |
| Aug-28-25 | Initiated | Ladenburg Thalmann | Buy |
| Feb-28-24 | Initiated | Evercore ISI | Outperform |
| Feb-27-24 | Initiated | BofA Securities | Buy |
| Feb-27-24 | Initiated | Morgan Stanley | Overweight |
Fractyl Health Inc Stock (GUTS) Latest News
Can Fractyl Health Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Low Drawdown Trading Techniques - ulpravda.ru
Is Fractyl Health Inc. stock a contrarian buyEarnings Miss & Risk Managed Investment Strategies - ulpravda.ru
Fractyl Health outlines strategic outlook for 2026 - MSN
Why retail investors favor Fractyl Health Inc. stockJuly 2025 Analyst Calls & Community Consensus Trade Alerts - ulpravda.ru
What margin trends mean for Fractyl Health Inc. stockLow Beta Stocks & Make Confident Moves With Forecasting Models - ulpravda.ru
Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness - The Globe and Mail
Fractyl Health, Inc. Announces Chief Financial Officer Changes - MarketScreener
Fractyl Health appoints Lara Smith Weber as new CFO By Investing.com - Investing.com South Africa
Fractyl Health Appoints New Chief Financial Officer - TipRanks
Fractyl Health appoints Lara Smith Weber as new CFO - Investing.com
Why a metabolic disease company is bringing in a new finance chief - Stock Titan
Fractyl Health announces catalyst-rich clinical and funding outlook - MSN
Fractyl Health: Advancing Revita and Rejuva Pipelines Toward 2026 Clinical and Regulatory Catalysts Supports Buy Rating - TipRanks
Fractyl Health Announces Catalyst-Rich Clinical and Funding Outlook - TipRanks
Millions stopping GLP-1 drugs face what's next as firm tests new option - Stock Titan
Fractyl Health’s REVEAL-1 study shows positive six-month results for Revita in maintaining weight and glycemic control post-GLP-1 use - MSN
Analysts Keep Buy Ratings on Fractyl Health (GUTS) - Finviz
Analysts keep buy ratings on Fractyl Health (GUTS) - MSN
Fractyl Health’s REVEAL-1 Study Shows Positive Six-Month Results for Revita in Maintaining Weight and Glycemic Control Post-GLP-1 Use - Yahoo Finance
More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals
Stop Loss: Why Fractyl Health Inc stock remains undervaluedWeekly Volume Report & Trade Opportunity Analysis - moha.gov.vn
Aug EndMonth: Why retail investors favor Fractyl Health Inc stock2025 Investor Takeaways & Low Volatility Stock Suggestions - moha.gov.vn
Entry Recap: Why Fractyl Health Inc stock remains resilientJuly 2025 Snapshot & AI Powered Market Entry Ideas - moha.gov.vn
GUTS SEC FilingsFractyl Health 10-K, 10-Q, 8-K Forms - Stock Titan
Is Fractyl Health Inc. stock in correction or buying zoneWeekly Market Report & Daily Stock Trend Watchlist - Улправда
Aug Technicals: Why Fractyl Health Inc stock remains undervaluedJuly 2025 Recap & Fast Moving Market Watchlists - moha.gov.vn
Canaccord Genuity reiterates Buy rating on Fractyl Health stock By Investing.com - Investing.com South Africa
Canaccord Genuity reiterates Buy rating on Fractyl Health stock - Investing.com
Why Fractyl Health Inc. stock remains resilient2025 Historical Comparison & Technical Entry and Exit Alerts - DonanımHaber
Why Fractyl Health Inc. stock is trending among retail tradersSwing Trade & Smart Money Movement Tracker - Улправда
Fractyl Health (GUTS) officer awarded 845,226 stock options at $2.24 - Stock Titan
Market Overview: Will Fractyl Health Inc. stock deliver shareholder value2025 Stock Rankings & Daily Profit Focused Stock Screening - Улправда
Will Fractyl Health Inc. stock deliver shareholder valueJuly 2025 Catalysts & Trade Opportunity Analysis Reports - Улправда
With 58% institutional ownership, Fractyl Health, Inc. (NASDAQ:GUTS) is a favorite amongst the big guns - Yahoo Finance
Fractyl Health (GUTS) officer receives 743,913 stock options at $2.24 - Stock Titan
Fractyl Health (GUTS) CEO receives 2,486,302 stock options grant - Stock Titan
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Fractyl Health Calls Tranche A Warrants - TipRanks
Fractyl Health Announces Call of Tranche A Warrants - TradingView — Track All Markets
Fractyl Health calls Tranche A warrants for exercise or cancellation By Investing.com - Investing.com Canada
Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones - The Manila Times
Fractyl Health (NASDAQ: GUTS) sets Dec. 30 deadline on Tranche A warrants - Stock Titan
Fractyl Health Inc Stock (GUTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.80%
4.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):